GW-1000-02
GWMS0001 Part B
Phase 3 small_molecule completed
Quick answer
GW-1000-02 for Multiple Sclerosis is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Multiple Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed